Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
126 Cards in this Set
- Front
- Back
What is innate immunity?
|
-Nonspecific, present regardless of antigen exposure
-Intensity of response doesn't increase with repeat exposure -1st part: factors that prevent microbes from entering (intact epithelium, cilia in resp., alveolar macrophages) -2nd part: factors that destroy/limit growth of pathogens (NK cells, phagocytes, complement, interferon, iron sequestering proteins, fever, inflammation) (Basically all immunity that doesn't involve the actions of B or T cells after antigen exposure) |
|
What is adaptive/acquired immunity?
|
-Response of B or T cells after antigen exposure
-Characterized by memory (results in faster, stronger, more efficient response) |
|
Effector cells in innate immunity (6)
|
Neutrophils
Basophils Eosinophils Macrophages Mast cells NK cells (NOT B or T lymphocytes) |
|
Effector cells in adaptive/acquired immunity
|
B cells
Plasma cells Helper T cells (CD4) Cytotoxic T cells (CD8) |
|
Which chemical mediators are part of innate immunity? Which are acquired immunity?
Complement? Cytokines? Interferons? Lysosomal enzymes? Acute phase proteins? Antibodies? |
Complement - Innate (though can be activated by antibody/antigen complexes)
Cytokines - Acquired Interferons - Innate Lysosomal enzymes - Innate Acute phase proteins - Innate Antibodies - Acquired |
|
Cell mediated vs. humoral immunity
What does each defend against? |
Cell mediated:
1) Viruses, fungi, mycobacteria 2) Tumors 3) Hypersensitivity 4) Causes graft rejection Humoral: 1) Bacteria (some viruses and toxins can be neutralized by antibodies) |
|
Cell mediated vs. humoral immunity
Which elements are innate? Which are acquired? |
Innate:
-Cell mediated: macrophages, NK cells -Humoral: Complement, lysozyme Acquired: -Cell mediated: CD4 helper T cells, CD8 cytotoxic T cells -Humoral: Antibodies |
|
Antibodies can independently neutralize some viruses/toxins but require the help of ________ or _______ to kill bacteria.
|
complement (antibody-antigen complex bind C1)
or phagocytes (IgG is ligand for Fc receptor) |
|
T lymphocytes have T-cell receptors (TCRs) that interact with _____ on other cells.
|
major histocompatibility complex (MHC)
|
|
MHC class I vs. class II
Which is found on all cells? Which presents exogenous non-self peptides (obtained cia phagocytosis/endocytosis)? Which presents non-self peptides that have been processed intracellularly (i.e. viral infection)? Which marks the cell for destruction when presenting non self peptides? |
Which is found on all cells? Class I
Which presents exogenous non-self peptides? Class II Which presents non-self peptides that have been processed intracellularly? Class I Which marks the cell for destruction when presenting non self peptides? Class I |
|
Which cells present MHC class II?
|
Antigen presenting cells
(dendritic cells, macrophages, memory B cells) |
|
When MHC class II presents non-self peptides, it leads to activation of a ________ cell with the TCR appropriate for that peptide.
|
CD4+ Helper T cell
(leads to release of cytokines-->macrophage activation & proliferation of appropriate plasma cells) |
|
How do antibodies eliminate extracellular pathogens? Intracellular?
|
Extracellular: bind and opsonize (IgG) so phagocytic cells phagocytose it and present on MHC II to perpetuate humoral response; IgG/M can activate complement to lyse, neutralize or opsonize
Intracellar: IgG binds antigens on infected cells so cells with Fc receptor (phagocytes, NK cells) destroy them |
|
Which Ig is found as a dimer in secretions and a monomer in blood?
|
IgA
|
|
Which Ig is bound on the surface Fc receptors of tissue mast cells and blood basophils?
|
IgE
|
|
Which Ig mediates type 1 hypersensitivity?
|
IgE (allergic rxns)
|
|
correr
|
to run, to race, to flow
courrir |
|
Which Ig is the ligand for Fc receptors on NK cells or phagocytes?
|
IgG
|
|
Which Ig is most abundant in primary immune response? Secondary?
|
Primary=IgM
Secondary=IgG |
|
Which Ig can activate the classical complement pathway?
|
IgG and IgM
|
|
In the T-cell independent response, which antibodies can be made?
|
Only IgM
(memory B cells require a helper T cell for isotype switching and a secondary immune response to occur) |
|
How are there more unique Ig molecules than there are unique Ig genes?
|
Gene rearrangement
-The light chains (gamma and kappa) can be mixed and matched with heavy chains (1 for each isotype) -V, D, J segments can be rearranged in variable region |
|
Which complement components cause cell lysis?
|
C5b-C9 (form membrane attack complex)
|
|
Which complement components cause degranulation of mast cells and basophils?
|
C3a, C4a, C5a (anaphlylatoxins)
|
|
Which complement components cause opsonization of particulate antigens?
|
C3b, C4b (opsonins)
|
|
Which complement components cause chemotaxis of leukocytes (mainly PMNs)?
|
C5a, C3a, C5b67 (chemotactic factors)
|
|
Which complement components are involved in viral neutralization?
|
C3b, C5b-C9
|
|
Which complement components allow for solubilization and clearance of immune complexes?
|
C3b
|
|
How are each the 3 pathways of complement activated?
|
Classical: C1q binds antigen antibody complex (IgG/M) on pathogen surface
Mannose-binding lectin: acute phase protein (mannose binding lectin) binds mannose residues on pathogen leading formation of C3 convertase and follows classical pathway from there Alternative pathway: C3 is activate spontaneously by hydrolysis (usually by molecules with repeating chemical structures on pathogen surface; polysaccharides, lipopolysacchrides, teichoic acid) then follow classical pathway |
|
Which complement pathways require acquired immunity elements? Which don't?
|
Classical needs antibodies to start
MBL and alternative pathway don't (innate immunity) |
|
C1 esterase inhibitor deficiency
|
Overproduction in anaphlotoxins (C3a, C4a, C5a)
Leads to recurrent episodes of angioedema (degranulation of mast cells/ basophils) AD inheritance (hereditary angioneurotic edema) |
|
C3 deficiency
|
Reduced C3b predisposes to recurrent pyogenic infections
|
|
C5-C8 deficiency (or mannose binding lectin deficiency)
|
Greatly increase risk of Neisseria infections (C5b-C9 forms MAC which can kill most unencapsulated gram - organisms)
|
|
Decay accelerating factor deficiency
|
Paroxysmal nocturnal hemoglobinuria
Decay accelerating factor (on all human cells) destabilizes C3 and C5 convertase so can't make MAC on human cells |
|
Potent antigen presenting cell that forms extensive web in tissues for trapping and phagocytosing antigen
|
Dendritic cell (Langerhans cell in epidermis)
|
|
Which cells use oxygen dependent and indepent mechanisms to generate antimicrobial substances?
|
Neutrophils and macrophages
|
|
Found in blood and migrates into tissues to defend against parasites
|
Eosinophils
|
|
Effector mechanism of eosinophils
|
Exocytosis of granules containing extremely basic proteins (fight parasites)
|
|
What releases histamine and other vasoactive amines upon crosslinging of surface bound IgE by allergen?
|
Basophils (blood) and mast cells (tissues)
|
|
What cells do NK cells lyse?
|
Virally infected (antibody dependent) & tumor cells with decreased levels of MHC class I
|
|
Large, granular lymphocytes with no markers in common with B or T cells, not MHC restricted
|
NK cells
|
|
CD20+ lymphocyte with membrane bound Ig
|
B cell
|
|
B cells can endocytose and present antigen on _____ , thus functioning as antigen presenting cells in the activation of T helper cells
|
MHC II
|
|
Can free penicillin cause anaphylaxis?
|
No, can only bind one arm of an antibody. When bound to a carrier protein (i.e. amoxicillin) it can crosslink IgE and cause anaphylaxis
|
|
What type of hypersensitivity is anaphylaxis?
|
Type 1
|
|
Can anaphylaxis occur on the 1st exposure to an antigen?
|
No, produce IgE after a few days which bind to the Fc receptors on mast cells (sensitization). 2nd exposure cross-links the IgE bound mast cells and causes degranulation.
|
|
What is the treatment for anaphylaxis?
|
Epinephrine
-beta2 bronchodialates (leukotrienes bronchoconstricted) -alpha1 prevents vascular leakage and increases BP Diphenhydramine: H1 receptor antagonist (histamine usually causes vascular permeability and smooth muscle contraction) Methylprednisolone: -Works synergistically with epi -Inhibits phospholipas A2 so less arachidonic acid to make prostaglandins and leukotrienes |
|
Why are 2nd gen H1 receptor antagonists (fexofenadine/Allegra, loratadine/Claratin) better than 1st gen (diphenhydramine)?
|
2nd gen doesn't cross BBB so less drowsiness
|
|
Cromolyn sodium
|
Prophylactic inhibitor of mast cell degranulation; stabilizer (asthma/allergic rhinitis)
(can't treat once degranulation has occured) |
|
Anti-inflammatory
Block production of cytokines Treat allergic asthma |
Corticosteroids
|
|
Omalizumab
|
Monoclonal anti-IgE antibody (prevent IgE binding to receptors by binding receptor)
Treat severe asthma uncontrolled with corticosteroids |
|
Zileuton
|
5-lipoxygenase inhibitor (prevent leukotriene synthesis so no bronchoconstriction in asthma)
|
|
Zafirlukast, montelukast
|
Cysteinyl leukotriene receptor antagonists (less leukotriene effects=bronchodilation=asthma treatment)
|
|
Histamine and leukotrienes play a major role in __________ which involves bronchospasm, urticaria, hypotension, and GI problems
|
Anaphylactic shock
|
|
Pt. develops high indirect bilirubin, high reticulocytes, and + direct Coomb's test after taking antibiotic
What is this and what type of hypersensitivity? |
Drug induced warm autoimmune hemolytic anemia (AIHA)
Type II; antibiotic on RBC is bound as an antigen by IgG (extravascular hemolysis) |
|
What type of hypersensitivity reaction is serum sickness?
|
Type III
|
|
What is a type III hypersensitivity reaction? Does it require sensitization?
|
Antibody-antigen (immune) complexes deposit in tissues. Eventually causes the activation of complement.
Don't need sensitization if exogenous antigen is given in large excess at 1st exposure. |
|
What is the pathogenesis of serum sickness?
|
2 days to 2 weeks after patient exposed to foreign serum, IgG is produced in high enough amounts to make enough immune complexes (usually w/Fc regions of foreign antibodies as antigens) that can't be cleared fast enough and start depositing in tissues. Symptoms will subside once phagocytes clear antigen.
|
|
What are signs/symptoms of serum sickness?
|
1) Urticaria, tight throat, and facial swelling (anaphylatoxins from activated complement cause release of leukotrienes and histamine from mast cells)
2) Proteinuria, hematuria (immune complex deposition in renal glomeruli (like post strep glomerular nephritis)) 3) Joint pain (immune complex deposition in synovial tissue) Symptoms present about 2 days to 2 weeks after serum given (need time to make IgG) |
|
Does serum sickness increase or decrease serum complement levels?
|
Decrease, use it up
|
|
Administration of non-human antibodies can lead to _________, but making the Fc region nonantigenic can avoid this.
|
serum sickness
(chimeric antibody=Fab nonhuman, Fc human) |
|
2 types of contact dermatitis
|
Allergic type (contact with irritant one has been immunologically sensitized to like poison ivy; rxn can be more severe with each subsequent exposure)
Irritant type (repetitive irritation like washing) |
|
Which type hypersensitivity?
IgE mediated immediate hypersensitivity |
Type I
|
|
Which type hypersensitivity?
Mast cell degranulation induced by allergen cross-linked IgE |
Type I
|
|
Which type hypersensitivity?
Anaphylaxis, allergic rhinitis, bronchial asthma |
Type I
|
|
Which type hypersensitivity?
Atopic dermatitis |
Type I
|
|
Which type hypersensitivity?
Antibody mediated cytotoxic hypersensitivity |
Type II
|
|
Which type hypersensitivity?
Antibodies directed against cell bound antigens induce destruction of cells or tissues |
Type II
|
|
Which type hypersensitivity?
Transfusion reactions, hemolytic disease of the newborn, autoimmune hemolytic anemia |
Type II
|
|
Which type hypersensitivity?
Immune complex mediated hypersensitivity |
Type III
|
|
Which type hypersensitivity?
Antibodies directed against soluable serum antigen form immune complexes that deposit in tissues. Damage is complement mediated (lysis and neutrophil attraction) |
Type III
|
|
Which type hypersensitivity?
Post strep glomerulonephritis, serum sickness |
Type III
|
|
Which type hypersensitivity?
Systemic lupus erythematosus, rheumatoid arthritis, hypersensitivity pneumonitis |
Type III
Also post strep glomerulonephritis, serum sickness |
|
Which type hypersensitivity?
Cell-mediated delayed hypersensitivity |
Type IV
|
|
Which type hypersensitivity?
Antigen specific helper T cells activate tissue macrophages and stimulate local inflammation over 12-72 hrs |
Type IV
|
|
Which type hypersensitivity?
Contact dermatitis, tuberculin-type/granulomatous hypersensitivity, acute graft rejection |
Type IV
|
|
Which type hypersensitivity?
Decreased complement in serum |
Type III
|
|
Which type hypersensitivity?
+ direct and indirect Coombs test |
Type II
|
|
What is the principle mediator (cell or Ig) of each type of hypersensitivity?
|
I: IgE
II: IgG or IgM III: IgG IV: Helper T cell 1 |
|
SCID involves what cell types?
|
T cells (absent)
B cells (low normal to absent) NK cells (normal to low) |
|
What types of pathogens are infants w/SKID more susceptible to?
|
Opportunistic infection with intracellular organisms
(No cell mediated immunity b/c no T cells. Humoral is compromised too but babies have mom's IgG (transplacental) and IgA (breast milk). After about ~6mo old, have problems with humoral too.) |
|
How do you treat SCID?
|
Bone marrow transplant (or else fatal)
|
|
Baby with multiple infections (esp. intracellular), weight loss
Normal numbers of CD20+ cells, absence of CD3+ cells, unresponsive to B & T cell mitogen (pokeweed) |
SCID
T cells (absent) B cells (low normal to absent) NK cells (normal to low) |
|
Mutations in gamma subunit of IL-2 receptor is found in the most common type of SCID (X-linked). How does this mutation cause disease?
|
This subunit is important in the functioning of many IL receptors responsible for development/proliferation of B and T cells
|
|
Primary immunodeficiency in child with normal cell mediated immunity but absent plasma immunoglobulins
|
Bruton's agammaglobulinemia
|
|
Bruton's agammaglobulinemia is a defect in _____.
|
B cells (and thus immunoglobulin)
|
|
Which common immunodeficiency is associated with anaphylactic transfusion reactions?
|
IgA deficiency (most common immunodeficiency)
(Defect in heavy chain isotype switching. Develop IgE against IgA.) |
|
Child with frequent infections with staph and other catalase + organisms. Normal WBC count and serum antibodies in high-normal range
|
Chronic granulomatous disease
|
|
What is deficient in chronic granulomatous disease?
|
Mutation in gene for NADPH oxidase (catalyzes production of superoxide which is used to make hydrogen peroxide by SOD)
|
|
What are 2 mechanisms a phagocyte can use to kill phagocytosed bacteria?
|
1) Respiratory burst (NADPH oxidase catalyzes produciton of superoxide. SOD converts that to H2O2)
2) Myeloperoxidase converts H2O2 to hypoclorite (HOCl-) (Can also kill with lysozyme and cytotoxic peptides without using O2) |
|
What's in a granuloma and why are they formed?
|
Collection of epitheliod cells (modified macrophages) and giant cells (fusion of may macrophages) surrounded by a firbous capsule
Wall off an intracellular pathogen that is resistant to elimination (but can be sterile) |
|
Patients with chronic granulomatous disease are most susceptible to which organisms?
|
Staph aureus, Serratiea, Burkholderia cepacia, Asperfillus, and Candida
(can kill catalase - strep by stealing H2O2 made by strep and converting it to hypochlorite with myeloperoxidase) |
|
Neutrophils and macrophages fail to reduce nitroblue tetrazolium
|
Chronic granulomatous disease (no oxidative respiratory burst)
|
|
Autosomal recessive disorder in which lysosomes of neutrophils are incapable of fusing with phagosomes. Normal nitroblue tetrazolium.
|
Chediak-Higashi
Unlike CGD, susceptible to staph AND strep (catalase -) and has functional NADPH oxidase |
|
Facial abnormalities, cleft palate, micrognathia, hypocalcemia, lymphopenia, boot shaped heart, absent thymic shadow
|
DiGeorge
|
|
Which pouches are not properly formed in DiGeorge syndrome?
|
Third pouch:
-Thyroid -Inferior 2 parathyroid glands Fourth pouch: -Superior 2 parathyroid glands |
|
What is the inheritance of DiGeorge syndrome? What is mutated?
|
AD
microdeletions on Q arm of chr22 |
|
Classic manifestations of DiGeorge syndrome?
|
Congenital heart abnormalities (i.e. truncus arteriosus or tetralogy of Fallot)
Abnormal facial features Thymic aplasia Cleft palate Hypocalcemia (hypoparathyroidism) 22q deletion (CATCH-22) |
|
How are T cells selected in the thymus?
|
Positive and negative selection ensures mature T cells will be MHC restricted and self-tolerant respectively.
(T cells that bind MHC don't undergo apoptosis (+). T cells that bind self peptide in association with MHC undergo apoptosis (-)) |
|
Which is affected in DiGerorge syndrome: humoral or cell-mediated immunity?
|
Initially cell mediated b/c no thymus to mature T cells.
Eventually humoral (need heper T cells and their cytokines for B cell proliferation and differentiation. Lose humoral at ~6mo old as maternal antibodies drop off. |
|
Brutton's agammaglobulinemia (X-linked hypogammaglobulinemia)
What type of immune deficiency? Immune defect? Susceptibility? |
B-cell deficiency
Few to no B cells (only Ig is IgG found at very low levels) Recurrent pyogenic infections after 6mo old |
|
IgA deficiency
What type of immune deficiency? Immune defect? Susceptibility? |
B cell
B cell fails to produce IgA Recurrent sinus, respiratory, and GI infections (IgA is found in secretions) *Anaphylactic transfusion rxns |
|
X-linked hyper-IgM syndrome
Immune defect? Susceptibility? |
No B0 cell class switching from IgM to other isotypes due to defect in CD40 ligand or other problem in interaction between B0 cell and helper T cell
Pyogenic infections; poor response to immunization |
|
Common variable immunodeficiency
What type of immune deficiency? Immune defect? Susceptibility? |
B cell
Late onset (25-30yo) agammaglobulinemia that has acquired and inherited characteristics; commonly follows viral infection Pyogenic infections, increased risk of various autoimmune dz. and lymphoma |
|
DiGeorge syndrome
What type of immune deficiency? Immune defect? Susceptibility? |
T cell
T cell deficit due to thymic dysplasia Opportunistic viral and fungal (need cell mediated immunity) |
|
Chronic mucocutaneous candidiasis
What type of immune deficiency? Immune defect? Susceptibility? |
T cell
T cell dysfunction specific to Candida albicans |
|
Chronic granulomatous disease
What type of immune deficiency? Immune defect? Susceptibility? |
Phagocyte deficiency
Phagocytes lack NADPH oxidase so can't produce H2O2 to kill bacteria with catalase Catalase + bacteria, certain fungi; widespread granuloma formation |
|
Chediak-Higashi syndrome
What type of immune deficiency? Immune defect? Susceptibility? |
Phagocyte deficiency
Lysosomes can't fuse with phagosomes Staph and strep (catalase - susceptible unlike CGD) |
|
Leukocyte adhesion deficiency
Immune defect? Susceptibility and other features? |
Defective neutrophil integrin (LFA-1 mediated adhesion) so defective migration
Severe pyogenic infections; delayed umbilical cord separation |
|
What is used to screen for HIV? What test is confirmatory?
|
Screen: ELISA
Confirm: Western blot (pt.'s antibodies react with HIV proteins in acrylamide gel) |
|
What drug classes are used in highly active antiretroviral therapy (HAART)?
|
Nucleoside analog reverse transcriptase inhibitors:
reverse transcriptase puts them into DNA strand where they block further extension (Zidovudine (AZT), lamivudine, etc.) Nonnucleoside analogs (reverse transcriptase inhibitors): delavirdine, nevirapine, etc. Protease inhibitors: bind and inhibit protease (all end in -navir) |
|
Missing doses of HAART therapy can rapidly lead to resistance because __________ is extraordinarily error-prone.
|
HIV reverse transcriptase
(can result in mutation that leads to drug resistance if virus can replicate while sporadically using HAART) |
|
What type of virus is HIV?
What cell types does it infect? |
Encapsulated retrovirus
Infects CD4+ T cells (and macrophages, dendritic cells, and microglial cells that express appropriate coreceptor for gp120 and gp41 on viral envelope) |
|
Once macrophages or dendritic cells are infected with HIV, they express DC-SIGN which allows them to bind and directly infect _____.
|
T cells
|
|
What are 3 major mechanisms of CD4+ T cell depletion in HIV infection?
|
1) Viral replication in T cell --> host cell lyses and release virions
2) Expression of HIV peptides on infected cells --> cytotoxic T cells recognize and kill 3) Activation of uninfected CD4+ T cells --> activation induced apoptosis |
|
When is an HIV+ pt. considered to have AIDS?
|
T cells <200/microL
or presents with one of the AIDS defining opportunistic infections/malignancies |
|
HIV with gp120 an gp41 infects T cells that express ____ and either CXCR4 or CCR5. It can also infect phagocytic cells.
|
CD4+
|
|
What is the most common significant opportunistic infection in HIV patients? How does it present?
|
Pneumocystis jiroveci
Pneumonia with diffuse symmetric intersititial infiltate (usually in pts. with T cell < 200/microL) |
|
What should an HIV patient be on as prophylaxis for PCP?
|
Trimethoprimsulfamethoxazole (can treat it too)
|
|
Anti transplant rejection drug that inhibits calcineurin (prevents transcription of important cytokines like IL-2)
|
Cyclosporine
(can cause nephrotoxicity and HT) |
|
Hyperacute rejection
|
Preformed anti-ABO antibodies occlude vessels of graft w/in minutes of transplant (organ turns white during surgery)
|
|
Acute rejection
|
T cell mediated destruction of graft parenchyma usually due to human leukocyte antigen (HLA) mismatches.
Occurs w/in days-weeks. Can be treated with immunosuppressive drugs |
|
Chronic rejection
|
Graft vascular damage seen months to years after transplantation
(could be caused by antibodies or immunosuppresive drug adverse effects, like OKT3) |
|
What are anthithymocyte globulin and OKT3 used for?
|
Immunosuppression (prevent graft rejection)
Both antibodies against lymphocytes (AGT is heterologous antibody against T cells) (OKT3, aka muromonab, is antibody against CD3. Inhibits T cell recognition of alloantigen and reduces T cell counts) |
|
In graft vs. host disease, donor _____ attack immunocompromised host.
|
T cells
|
|
In graft vs. host disease, which tissues are most affected?
|
Skin and GI
(2 major sites of pathogen entry so have cells with high MHC expression density) |